MENU
ACLX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Arcellx (ACLX) Earnings Date & Reports

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases... Show more

A.I. Advisor
published Earnings

ACLX is expected to report earnings to fall 12.82% to -75 cents per share on May 08

Arcellx ACLX Stock Earnings Reports
Q1'25
Est.
$-0.76
Q4'24
Missed
by $0.31
Q3'24
Missed
by $0.14
Q2'24
Beat
by $0.01
Q1'24
Beat
by $0.37
The last earnings report on February 27 showed earnings per share of -87 cents, missing the estimate of -55 cents. With 416.10K shares outstanding, the current market capitalization sits at 3.34B.
View a ticker or compare two or three
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
800 Bridge Parkway
Phone
+1 240 327-0603
Employees
130
Web
https://www.arcellx.com